European Biopharmaceutical Enterprises’, EBE’s, position on European Medicines Agency’s Draft Policy for Clinical Trial Data Sharing
European Biopharmaceutical Enterprises, EBE, a specialised group of European Federation of Pharmaceutical Industries and Associations, EFPIA, represents the voice of biopharmaceutical companies of all sizes in Europe that use biotechnology to discover, develop and bring new medicinal products to market. Majority of EBE members are micro, small and medium sized companies.
EBE recognises the potential scientific and public health benefits of providing greater access to information from clinical trials. EBE Supports EFPIA’s response (5 September 2013) to the EMA consultation on Draft Policy for Clinical Trials Data Sharing Policy.